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Introduction
On 14 April 2003 Homo sapiens became the
ﬁrst species on earth to ﬁnish reading its own
set of instructions. However, although we have
read our code, the problem that now faces us is
to understand what we have read. The ﬁrst task
towards this understanding is to establish the full
catalogue of human genes based on the genome
sequence. Although evidence is accumulating that
questions our assumptions about what constitutes
a gene and it seems possible that we may have to
broaden our horizons to include various classes of
non-protein coding RNAs, a ﬁrst generation gene
catalogue must inevitably be focused on protein-
coding genes.
This layering of information onto sequence is
widely called ‘annotation’ and we term the spe-
ciﬁc process of describing gene structures on the
genomic sequence ‘gene annotation’. Although
ultimately the genome sequence should be accom-
panied by an information-rich annotation describ-
ing many aspects of structure and function, for
the moment accurately describing gene structures
remains a considerable task. Despite progress in
methods for gene prediction, and the availability of
genome sequence from other mammals for com-
parative analysis, deriving the gene catalogue by
computation is still an imperfect art (Guigo et al.,
2000). On the other hand, curation of gene struc-
tures supported by experimental data, either from
the cDNA and EST databases, or more unusually
from de novo cloning and sequencing, is labour-
intensive and has not yet been applied to the
full genome. A particular problem is that most
cDNA libraries are derived from total cellular RNA
and contain a high proportion of unprocessed and
partially processed RNA species, confounding the
identiﬁcation of intron–exon junctions from ESTs
or cDNA sequences (Bashiardes and Lovett, 2000).
Thus, the protein coding gene catalogue is far from
complete. What we have instead are a series of
attempts to approximate or estimate what the gene
catalogue looks like, based on applying the current
favourite gene ﬁnding paradigms to the available
genome sequence (International Human Genome
Sequencing Consortium, 2001; Das et al., 2001;
Davuluri et al., 2001; Ewing and Green, 2000;
Flicek et al., 2003; Guigo et al., 2003; Liang et al.,
2000; Roest Crollius et al., 2000; Shoemaker et al.,
2001; Wright et al., 2001).
We have taken an alternative approach by con-
centrating on a single contiguous segment, repre-
senting 1% of the human genome, and attempting
to produce a highly curated gene annotation, sup-
ported by expressed sequences from the databases
and experimental conﬁrmation of gene structures
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by ampliﬁcation and sequencing from cDNA in
the laboratory (Collins et al., 2003; Dunham et al.,
1999). As far as possible we have established
canonical gene structures which include the 5  and
3  ends for every gene, giving a single compre-
hensive gene set. Our motivation for this approach
was that, in addition to producing a highly curated
dataset which could be used as a benchmark for
testing novel approaches to gene ﬁnding, extrapo-
lation from this 1% could lead to insights about the
full human gene set. The region that we chose to
study, for largely historical reasons, was the long
arm of human chromosome 22. This choice can
be criticized on the basis that 22q is a somewhat
exceptional region of the genome. It is unusually
GC-rich, Alu-rich, LINE-poor and replicates very
early in the cell cycle compared with other human
chromosomes. However, although these factors
make chromosome 22 exceptional as a chromo-
some, they also make 22q the typical environment
of the vast majority of protein-coding genes. Thus,
we believe that there is some value in describing
the overall properties of the chromosome 22 genes
as an indication of the qualities of the other human
genes.
Overall properties of the chromosome
22 gene annotation
We have recently published an extensive reanal-
ysis of the gene content of human chromosome
22 (Collins et al., 2003). In this gene annotation,
we aimed to identify genes, and their canonical
genomic structures, supported by evidence from
transcribed sequences across the entire gene length.
After subjecting the genomic sequence of chro-
mosome 22 to a suite of bioinformatic analyses,
we aligned full-length cDNA or assembled EST
to the genome and resolved splice sites and 3 
ends. We then extended incomplete genes, joined
5  and 3  EST clusters, or conﬁrmed prelimi-
nary gene structures by obtaining additional cDNA
sequence using directed cDNA or reverse transcrip-
tase (RT)–PCR and sequencing. All the fragments
sequenced were realigned to the chromosome 22
sequence and the gene structures were updated.
Having established the annotation, open reading
frames (ORFs) of greater than 300 bases were
identiﬁed and we categorized the genes based on
their structural features. Essentially, genes with
support from transcribed sequences with identiﬁ-
able ORFs were split into either complete or par-
tial protein-coding genes depending on whether a
5  and 3  end had been conﬁrmed according to
deﬁned criteria. Other structures supported by tran-
scribed sequences but without ORFs were classi-
ﬁed as non-coding RNAs. In addition, we anno-
tated a series of processed and duplicated pseu-
dogenes and postulated that some of the partial
genes, while still containing ORFs and so not
meeting our deﬁnition of a pseudogene, may rep-
resent ‘prepseudogenes’. Table 1 of Collins et al.
Table 1. Basic properties of genes on human chromosome 22
All structures Genes with ORF ORFs Pseudogenes
Number of annotations 936 461 461 234
Total genomic coverage 18.6 Mb (55%) 17.0 Mb (50.3%) 13.9 Mb (41.1%) 0.84 Mb (2.5%)
Mean gene size 19921 36960 30190 3580
Median gene size 3730 16451 12319 1468
Mean exons per gene 5.5 9.1 8.4 2.2
Median exons per gene 3 7 6 1
Mean exon size 350 317 171 685
Median exon size 139 134 122 216
Mean cDNA length 1935 2889 1454 1511
Median cDNA length 1392 2298 1104 1173
Total exon length 1.81 Mb (5.2%) 1.3 Mb (3.7%) 0.7 Mb (2%) 0.35 Mb (1%)
Total intron length 16.8 Mb 15.7 Mb 13.2 Mb 0.49 Mb
% removed as intron 90% 92% 95% NA
‘All structures’ refers to the complete annotation, including the gene segments of the immunoglobulin-λ cluster and pseudogenes. ‘Genes with
ORF’ includes only gene structures with an annotated ORF of 300 bases or greater, but not immunoglobulin-λ segments. Only 387 of these
genes were deﬁned as full-length. ‘ORFs’ refers to only the annotated ORF structures. Genomic coverage is calculated on the basis of the
fraction of the known sequence covered, excluding sequence gaps (33821 705 bp). Unless otherwise indicated, sizes are in bases.
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(2003) summarizes the distribution of gene struc-
tures between these categories and is the starting
point for the additional characterizations we report
here. The complete annotation set and the associ-
ated reference sequence are archived and available
at http://www.sanger.ac.uk/HGP/Chr22.
Table 1 shows the summary characteristics
of chromosome 22 genes from the annotation
described in Collins et al. (2003). Overall, 55% of
the 33.8 Mb of 22q genomic sequence is covered
by gene structures, including non-protein-coding
genes and pseudogenes. If we ignore pseudogenes,
non-coding RNAs and the gene segments of
the immunoglobulin-λ gene cluster, then classical
protein-coding genes cover 51% of 22q. Only 3.7%
of the 22q sequence is protein coding gene exon,
and a mere 2% of the sequence actually codes for
amino acids. Looking at this in another way, while
at least 51% of the sequence is transcribed, 92% of
the transcribed sequence is removed by processing
before mature message is produced. Pseudogenes
are an order of magnitude smaller than protein-
coding genes, but are numerous and cover 2.5%
of 22q, or 1% if intronic sequences are ignored.
Thus, the amounts of the chromosome given
over to protein coding exons and pseudogenes
are surprisingly similar. For this paper, we will
concentrate on the properties of the protein-coding
genes on chromosome 22.
The structure of protein-coding genes
Gene size and exon number
A typical protein coding gene is about 36.9 kb in
length and contains 9 exons. However, these ﬁgures
mask a distribution with a long tail containing a
small number of genes, which are either genomi-
cally large, or have many exons, or both. Figure 1
illustrates this distribution for the genomic span of
chromosome 22 genes. The largest gene, cB42E1.1,
is 701 kb in length and is followed by genes
spanning 647 kb (LARGE) and 544 kb (SYN3).
The genes with the largest genomic expanse are
not the ones with the most exons, these being
instead PICK4CA with 55 exons across 150 kb
and MYO18B with 44 exons spanning 288 kb.
However, there is a signiﬁcant general relation-
ship between gene size and exon number with
larger genes having more exons [Figure 1C; Spear-
man correlation coefﬁcient (r) = 0.6844 at p <
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Figure 1. Distributions of exon number and gene size for
387 chromosome 22 full-length protein-coding genes
0.0001]. At the other end of the spectrum, 19 genes
which meet our criteria for full-length protein-
coding genes consist of only a single exon, with
some smaller than 2 kb in length.
Genomic locations and GC content
It has long been known that genomically large
genes tend to reside in GC-poor, Alu-poor and
LINE-rich regions of the genome, whereas small
genes reside in genomic regions with the opposite
characteristics (Duret et al., 1995). This is con-
ﬁrmed for the chromosome 22 protein coding gene
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Figure 2. The relationship of gene length to GC content. GC content was calculated for the genomic span of each of
the 387 full-length protein-coding genes and plotted against log10 of the gene length. Pearson’s correlation coefﬁcient was
determined as −0.5728 at p < 0.0001
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Figure 3. GC content distributions for genes and total chromosome 22 DNA. The whole chromosome 22 sequence and
the intragenic sequence for the 387 full-length protein-coding genes only were analysed for GC content in non-overlapping
20 kb windows. The distributions were then adjusted so that the frequencies summed to 1
set in Figure 2 which shows the inverse corre-
lation between GC content of the genomic span
of the gene and log10 of gene length [correlation
coefﬁcient (r) =− 0.5728 at p < 0.0001]. As has
previously been pointed out, this effect is due to
increased intron lengths in GC-poor regions (Inter-
national Human Genome Sequencing Consortium,
2001), and exon number is only weakly inversely
correlated with GC content (data not shown). How-
ever, contrary to expectations from the whole
genome, there is little difference in the patterns of
GC content between the regions of chromosome
22 that contain genes (intragenic) and those that
do not (intergenic). Figure 3 shows the distribu-
tion of GC contents for the genomic spans of the
chromosome 22 protein-coding genes in 20 kb non-
overlapping windows compared to the overall GC
content of chromosome 22. The distribution of GC
content for chromosome 22 sequence as a whole
is remarkably similar to that for the genes alone
(as is the distribution for intergenic DNA alone;
data not shown) which is unlike the equivalent
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Figure 4. Distributions of exon sizes for 461 chromosome 22 genes with ORFs. (A) Frequency distribution for all
chromosome 22 protein-coding exons by length. The combined frequencies for all exons greater than 2000 bp in size
are grouped in the frequency bar at the right of the distribution. (B) Frequency distribution for all chromosome 22
protein-coding exons by length, broken down by exon type. The top panel shows the frequency distribution for internal
exons (black bars), with the inset showing a blow-up of the class intervals up to 1 kb. The bottom panel shows the same
distribution for 5  (black) and 3  (grey) exons. Length class interval labels refer to the upper limit of the interval, i.e. 50
represents the interval 1–50 bases, etc.
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Figure 5. Summary statistics for different exon types for the 461 protein-coding genes. The diagram at the top represents
a prototypical exon/intron structure for a chromosome 22 gene, with the boxes representing the exons, and the hashed
regions representing the most common exon organization of the ORF. Statistics for each type of exon are given underneath.
Smallest exon sizes for 5  and 3  exons are not given, as we cannot be sure we have annotated to the full extremity of
these exons in some cases
distributions for the whole genome (see Figure 36
of International Human Genome Sequencing Con-
sortium, 2001). Thus both intra- and intergenic GC
content are shifted towards a higher GC-content on
chromosome 22 than is seen for the whole genome.
This difference appears to be because chromosome
22 does not contain the large, GC-poor gene deserts
that are found elsewhere in the genome. In fact
several substantial regions of 22q13 contain no
annotated genes but are extremely GC-rich.
Exon and intron structure
Looking in more detail at the structure of the
protein-coding genes, a typical gene codes for
a cDNA of 2–3 kb in 7–9 exons. The mean
and median exon sizes are given in Table 1 and
the distribution of exon sizes for all exons is
shown in Figure 4A. However, examining exon
sizes grouped by type of exon presents a more
accurate picture, since 5  exons and particularly 3 
exons are both generally larger than internal exons,
and have a more varied distribution (Figure 4B).
Figure 5 summarizes the descriptive statistics for
each type of exon. As was seen previously (Inter-
national Human Genome Sequencing Consortium,
2001) it is notable that most internal exons are
tightly grouped around the 101–150 bp interval,
with only a handful of very short exons, the very
smallest of which have a purine bias (61.5% purine,
38.5% pyrimidine for exons of <19 bp). The small-
est internal exon is 6 bp in bK57G9.2. Some large
internal exons do occur, with the largest being
5209 bp. Of more interest is that with this chromo-
some 22 dataset, where we have carefully deﬁned
the extent of the 5  and 3  exons, we are able to give
more accurate statistics for these exons than has
previously been possible. For the 5  exons, the dis-
tribution peaks around the 101–150 bp interval and
has a median of 185 bp. However, there is a much
longer tail than seen with internal exons, reﬂect-
ing the general tendency for 5  exons to be larger
and more variable in length than internal exons.
Looking at 3  exons, the distribution is much ﬂat-
ter and ranges up to much larger exons, giving a
median of 857 bp. The largest 3  exon is 12.9 kb, in
the dJ1042K10.4 mRNA. Thus, 3  exons are appar-
ently unconstrained in size, unlike internal exons,
presumably due to independence from the restric-
tions of the splicing machinery.
Ten pairs of protein coding gene structures
overlap with each other, half orientated head-to-
head, and half tail-to-tail. A further 21 pairs of
the full-length protein-coding genes (10.7%) are
orientated head-to-head, with transcriptional starts
within 2 kb of each other. In all cases, a single
CpG island is located between the genes, which
might act as the promoter. These are candidates to
be under the control of a bidirectional promoter.
The introns of genes are generally regarded as
of little interest. However, on chromosome 22 we
identiﬁed 11 protein-coding genes which lie within
a single intron of another gene on the opposite
strand. Four of these ‘genes within genes’, TIMP3,
SERPIND1, GNAZ and U51561.2, are complete.
The remaining seven are partial genes, of which
three are spliced. A further three snoRNA genes
lie in the same transcriptional orientation within
introns of the RPL3 gene. There is also a length
bias observed for the ﬁrst intron of full-length
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Figure 6. Sequence Logo (Schneider and Stephens, 1990) showing the splice donor and acceptor consensus sites in 3857
chromosome 22 conﬁrmed introns
genes. A comparison of the lengths of the ﬁrst
intron of complete genes with more than two
exons to the mean lengths of the remaining introns
showed that the difference is signiﬁcant and the
ﬁrst intron is on average 1.8 times larger (compar-
ing medians, Wilcoxon matched-pairs signed-ranks
test p < 0.0001). This phenomenon means that the
transcriptional start and the ﬁrst exon of a gene can
often be at considerable distance from the remain-
ing coding exons. It has previously been speculated
that this size difference could be consistent with
transcriptional control features being present in the
ﬁrst introns (Chen et al., 2002), although it could
also be consistent with less constraints on intron
size for the ﬁrst intron, given that some can be
many tens of kilobases in size.
Splice sites
Analysis of 3857 introns from all the chromosome
22 annotations except pseudogenes shows a high
similarity to the splice donor and acceptor consen-
sus motifs deﬁned from a study of ∼1800 introns
by Stephens and Schneider (1992) (Figure 6). The
only variations are bases 18–20 of the splice accep-
tor where thymidine is most frequent in Stephens
and Schneider, but in this analysis cytosine is more
common. Only three out of 3857 acceptor sites
are not preceded by an intron ending with AG,
instead they have AC, TC or GT. At the splice
donor site, 23 introns do not begin with the canon-
ical GT, instead beginning with GC 15 times, AT
three times, GA twice, and TA, CT and CC once
each. The gene CACNA1I not only contains the
only U12-type AT-AC intron in this set (Mittman
et al., 1999), but also two GC splice donor sites,
making it the only gene to have more than one
variation from the splice consensus.
5  Ends and promoters
In silico prediction of candidate promoter seq-
uences or transcriptional starts has been the sub-
ject of considerable effort recently (Davuluri et al.,
2001; Down and Hubbard, 2002; Scherf et al.,
2000). We examined our set of 391 annotations
that had been assigned a probable 5  end and
ascertained the success of a series of promoter or
Table 2. Results of promoter prediction programs
compared to 391 chromosome 22 genes with probable
5  ends
Method
Total
predictions
True
promoters
matched
(sensitivity)
Proportion of
true promoter
matches
(speciﬁcity)
CpG Islands 546 324/391 (83%) 331/546 (61%)
Eponine 2055 274/391 (70%) 1313/2055 (64%)
Genomatix 418 280/391 (72%) 279/418 (67%)
First EF 1447 227/391 (58%) 637/1447 (44%)
All 4466 361/391 (92%) 2560/4466 (57%)
The genomic sequence was searched with CPGFIND (Micklem,
unpublished), which predicted a CpG island if the GC content was
greater than 60%, the ratio of observed CpG frequency/expected
CpG frequency was greater than 0.6 and there were more
than 200 bases of CpG island DNA. Eponine was downloaded
from http://www.sanger.ac.uk/Users/td2/eponine and was run
on the sequence with the threshold set at 0.999. Analyses for
PromoterInspector (Scherf et al., 2000) and First-EF (Davuluri et
al., 2001) were obtained from the websites as described in the
publications. Promoter predictions were then compared against
annotated 5  ends, and declared a match if they were within 1 kb. The
resultsareexpressedaseitherthenumberoftruepromotersmatched
out of the target set of 391 promoters (i.e. the sensitivity) or as the
number of predictions matching to the target set of promoters out
of the total number of predictions (i.e. the speciﬁcity). Calculations
are on a per-gene basis, so that where two genes are close in
head-to-head orientation, identifying this start is counted twice.
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transcriptional start prediction programs in identi-
fying the sequences directly overlapping or 5  of
these annotations (Table 2). Surprisingly, the best
results, in terms of sensitivity to detect real pro-
moters/gene starts, are obtained with the oldest
method, simply detecting CpG islands (CPGFIND).
The speciﬁcity of this method is slightly lower
than the others, but only fractionally. Thirty-seven
of the 67 gene starts which were not detected by
CPGFIND were detected by Genomatix, Eponine
or First EF, so that only 30 (7.6%) of the proba-
ble 5  ends were not predicted. First EF made the
major contribution to the additional 37 promoters
identiﬁed, which were not detected by CPGFIND.
Based on this experience, and given that at least
60% of human genes have CpG islands, ﬁnding
CpG islands should always be the ﬁrst approach
for prediction of promoters. However, a small but
signiﬁcant gain can be obtained using multiple pre-
diction programs. It should also be noted that the
speciﬁcity of all the methods is not optimal and,
although some of this is due to our exclusion of
partial genes in this analysis, at least 30% false
positives can be expected. Since chromosome 22 is
particularly GC-rich, this gene set may be biased
towards genes with CpG islands and the other pre-
diction programs may be more valuable in other
genomic regions.
3  Ends and polyadenylation sites
A total of 447 chromosome 22 annotations had
a conﬁrmed 3  end, based on the presence of a
polyA tract in an exact match expressed sequence
which was not found in the genomic sequence.
We analysed the ﬁnal 60 bases of each of these
sequences for the presence of putative polyA addi-
tion signal hexamers. The most common hexamer,
AATAAA (Beaudoing et al., 2000), accounted for
303 (68%) annotations. The mean position of the
ﬁrst base in the hexamer was 25 bases from the 3 
end (SD = 7). ATTAAA was present in 66 (15% of
the total) of the remaining 3  ends. One base vari-
ants from the AATAAA motif were identiﬁed in
60 (13% of the total) of the 78 annotations which
did not contain either AATAAA or ATTAAA. The
ﬁnal 18 (4%) annotations contained a hexamer with
Figure 7. The distributions and positions of all possible polyA addition hexamers in the set of 447 conﬁrmed 3  ends.
Frequencies for each of the hexamers in the last 60 bases of each transcript are shown. Positions are plotted at the most
5  base of the hexamer, with coordinates measured in the 5 –3  orientation from the transcript terminus, setting the last
base of the transcript to be base −1
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Figure 8. Comparison of codon usage on chromosome 22 with all human genes. Bars show the usage for each
codon expressed as a percentage of all available codons for that amino acid. The human gene codon usage
table at http://www.kazusa.or.jp/codon/cgi-bin/showcodon.cgi?species=Homo+sapiens+[gbpri] (grey bars)
was compared to the codon usage data from 387 complete ORFs from chromosome 22 (black bars), using the
software tool gcua at http://gcua.schoedl.de/seqoverallex.html (Markus Fuhrmann, Lars Ferbitz, Amparo Hausherr,
Thomas Sch¨ odl and Peter Hegemann. Monitoring expression of nuclear genes in Chlamydomonas reinhardtii by using a
synthetic luciferase reporter gene. Manuscript in preparation, 2003). The mean difference in codon usage between the two
sets was 6.6%
two variations from AATAAA. Figure 7 shows the
distributions and positions of all possible polyA
addition hexamers in the set of conﬁrmed 3  ends.
Open reading frames
The mean size of all ORFs annotated on chro-
mosome 22 is 1454 bases. However, this includes
annotations that are not full-length. There are 387
annotations for which full-length ORFs can be
deﬁned, with a mean ORF length of 1531 bases.
The codon usage table for this set of ORFs is avail-
able at http://www.sanger.ac.uk/HGP/Chr22/
c22codonusage.html. Figure 8 shows that codon
usage for the subset of genes on chromosome 22
is similar to that for a large set of human genes,
but is biased towards use of G or C bases rather
than A or T in the third codon position. It is likely
that this reﬂects the GC-rich nature of chromo-
some 22 as GC content in the third codon position
(GC3) has previously been shown to correlate with
GC content of the gene environment (Clay et al.,
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1996). The mean GC3 for the chromosome 22
genes is 69.4% and GC3 is indeed highly correlated
with the GC content of the genomic segment con-
taining the gene [Spearman correlation coefﬁcient
(r) = 0.6891, p < 0.0001].
In addition to the conventional genetic code,
the chromosome 22 gene set also contains two
genes that incorporate selenocysteine (U) as an
alternative to terminating at a TGA codon. These
are AC005005.7 and TR. Altogether, at the time of
writing, there are 43 human cDNA entries in the
EMBL database that indicate use of selenocysteine
codons, so the frequency on chromosome 22 does
not appear excessive.
Kozak has proposed the scanning model for
initiation of translation, where a 40S ribosome
subunit/factor complex binds to the 5  end of the
transcript and migrates to the ﬁrst ATG with a
strong or adequate consensus (Kozak, 1999). We
Table 3. Analysis of Kozak consensus sequences for 391
ORFs
Kozak type Site Number %
Strongest GCCACCATGG 2 0.5
AnnATGn 143 36.6
Strong



GnnATGG 96 24.6
Strong total 241 61.6
GnnATGY 52 13.3
Adequate



YnnATGG 36 9.2
Adequate total 88 22.5
GnnATGA 25 6.4
Others



None found 37 9.4
Others Total 62 15.9
annotated ORFs based on the longest single ORF
found in the gene structure, independent of the
presence or absence of a Kozak site. Therefore,
we examined 391 annotations with an annotated
ORF and a 5  untranslated region greater than
three bases for the presence of a Kozak consensus
motif (Table 3). Two complete genes, NPTXR
and MN1, which have a CTP start codon rather
than an ATG start, were not included in this
analysis. 241 (61.6%) of these ORFs conformed
to the Kozak strong consensus (AnnATGN or
GnnATGG), 88 (22.5%) had an adequate consensus
(GnnATGY or YnnATGG) and 62 (15.9%) did
not conform to the Kozak consensus sequence.
Further analysis of the annotations without a Kozak
consensus ATG revealed 25 with a GnnATGA
motif. These included a number of well-studied
genes and therefore we proposed that this is an
alternative adequate initiation site. A compositional
analysis of these sites is shown in Figure 9. For 32
of the remaining 37 ORFs an alternative start codon
with a strong, adequate or GnnATGG consensus
was found downstream in the same coding frame
as the annotated longest ORF. In these cases, use
of the alternative downstream start would lead to a
mean reduction in size of the expressed peptide by
56 amino acid residues. In the remaining ﬁve gene
structures, there was either no suitable consensus
in any frame (one case) or a consensus in an
alternative frame that would result in a much
smaller protein (four cases) and it does not seem
likely that these alternative starts are relevant.
354 of the 387 full-length ORFs terminate in
the last exon of the gene structure. A further 27
Figure 9. Sequence Logo (Schneider and Stephens, 1990) of Kozak site surrounding the initiator ATG
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ORFs terminate in the last but one exon of the
gene, and 19 of these terminate within 50 bases
of the last splice junctions. Thus 96.4% of the
annotations satisfy the criteria to avoid degradation
by nonsense-mediated decay (Maniatis and Reed,
2002; Maquat and Serin, 2001). Of the remaining
14 exceptions, eight ORFs terminate in the last
but one exon but are greater than 50 bases from
the splice junction. As far as we can tell, these
ORFs look bona ﬁde, and either nonsense-mediated
decay tolerates these examples or it plays some role
in regulation. For the remaining exceptions, it is
possible that alternative transcripts to the canonical
form that we annotated are the major functional
form. At the 5  end of the ORF there is slightly
less restriction as to the exon in which the ORF
begins, although the ﬁrst two exons are still heavily
favoured. 64% of ORFs initiate in the ﬁrst exon,
25% in the second exon, 7.5% in the third exon,
2.5% in the fourth, and the remainder in either the
ﬁfth or sixth exons.
Conclusions
We have outlined the genomic and coding proper-
ties of a highly curated set of human protein-coding
genes. Notwithstanding the caveat that this set rep-
resents one particular region of the genome that
may be unusual in terms of its GC content, it seems
likely that these properties will be characteristic of
most human genes. To further validate this gene
set we are now cloning and sequencing cDNAs to
obtain a representative clone for each full-length
ORF. These clones should be useful not only to
verify the collection but also to provide evidence
for the existence of each protein through expression
studies, generation of antibodies and perhaps RNAi
in tissue culture. In this way, we expect to begin to
generate an information-rich functional annotation
for at least this 1% of the human genome.
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